Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 83.68

+0.1%

Nov 28 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1118)	6/20/2005 10:56:43 PM
From: Jibacoa	Read Replies (2) of 3722

REGN Continued on its near term Uptrend that started on June 14 from the 6.18 level. It was up almost 13% at the close after it traded as H as 8.82 and the volume although less than Friday's still was more than 800 Ks.(more than double its average.) The stock was still trading higher AHs. bigcharts.marketwatch.com The results for the March Q were not good with revenues down to 16.2M and earnings of of $0.02/shr vs. $1.06 in 2004 REGN is expected to show a loss for 2005 of $1.80 and $1.90 in 2006 <g> However, it reportedly has around $6 in cash/shr and is CF & FCF + It has a pretty good pipeline including product candidates for Ca, RA,allergies, asthma, obesity,opthalmologic conditions and others It has some collaboration agreements with some of the large Cos. Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next